176 related articles for article (PubMed ID: 12099331)
1. Clinical features and antimicrobial susceptibility trends in Citrobacter freundii bacteremia.
Chen YS; Wong WW; Fung CP; Yu KW; Liu CY
J Microbiol Immunol Infect; 2002 Jun; 35(2):109-14. PubMed ID: 12099331
[TBL] [Abstract][Full Text] [Related]
2. Resistance to extended-spectrum cephalosporins and mortality in patients with Citrobacter freundii bacteremia.
Kim BN; Woo JH; Ryu J; Kim YS
Infection; 2003 Aug; 31(4):202-7. PubMed ID: 14562942
[TBL] [Abstract][Full Text] [Related]
3. Comparison of antimicrobial susceptibility of Citrobacter freundii isolates in two different time periods.
Wang JT; Chang SC; Chen YC; Luh KT
J Microbiol Immunol Infect; 2000 Dec; 33(4):258-62. PubMed ID: 11269372
[TBL] [Abstract][Full Text] [Related]
4. Citrobacter freundii bacteremia: Risk factors of mortality and prevalence of resistance genes.
Liu LH; Wang NY; Wu AY; Lin CC; Lee CM; Liu CP
J Microbiol Immunol Infect; 2018 Aug; 51(4):565-572. PubMed ID: 28711438
[TBL] [Abstract][Full Text] [Related]
5. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
6. Predictors of in-hospital mortality for bloodstream infections caused by Enterobacter species or Citrobacter freundii.
Deal EN; Micek ST; Ritchie DJ; Reichley RM; Dunne WM; Kollef MH
Pharmacotherapy; 2007 Feb; 27(2):191-9. PubMed ID: 17253909
[TBL] [Abstract][Full Text] [Related]
7. Clinical Characteristics and Antimicrobial Susceptibility Trends in
Lee R; Choi SM; Jo SJ; Lee J; Cho SY; Kim SH; Lee DG; Jeong HS
Infect Chemother; 2019 Mar; 51(1):1-9. PubMed ID: 30941932
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and predictors of mortality in patients with Enterobacter aerogenes bacteremia.
Chang EP; Chiang DH; Lin ML; Chen TL; Wang FD; Liu CY
J Microbiol Immunol Infect; 2009 Aug; 42(4):329-35. PubMed ID: 19949757
[TBL] [Abstract][Full Text] [Related]
9. Profile of microorganisms and antimicrobial resistance at a tertiary care referral burn centre in Iran: emergence of Citrobacter freundii as a common microorganism.
Khorasani G; Salehifar E; Eslami G
Burns; 2008 Nov; 34(7):947-52. PubMed ID: 18378087
[TBL] [Abstract][Full Text] [Related]
10. Detection and spread of carbapenem-resistant Citrobacter freundii in a teaching hospital in China.
Chen S; Hu F; Liu Y; Zhu D; Wang H; Zhang Y
Am J Infect Control; 2011 Nov; 39(9):e55-60. PubMed ID: 21705111
[TBL] [Abstract][Full Text] [Related]
11. Citrobacter bacteremia in a tertiary care hospital.
Gupta N; Yadav A; Choudhary U; Arora DR
Scand J Infect Dis; 2003; 35(10):765-8. PubMed ID: 14606621
[TBL] [Abstract][Full Text] [Related]
12. A small outbreak of third generation cephem-resistant Citrobacter freundii infection on a surgical ward.
Nada T; Baba H; Kawamura K; Ohkura T; Torii K; Ohta M
Jpn J Infect Dis; 2004 Aug; 57(4):181-2. PubMed ID: 15329453
[No Abstract] [Full Text] [Related]
13. [A case of severe pneumonia in an elderly man, caused by Citrobacter freundii suspected to have a low susceptibility to imipenem/cilastatin sodium].
Matsui S
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Nov; 32(11):1078-82. PubMed ID: 7815761
[TBL] [Abstract][Full Text] [Related]
14. Citrobacter infections in a tertiary care hospital in Northern India.
Mohanty S; Singhal R; Sood S; Dhawan B; Kapil A; Das BK
J Infect; 2007 Jan; 54(1):58-64. PubMed ID: 16815552
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological risk factors for isolation of ceftriaxone-resistant versus -susceptible citrobacter freundii in hospitalized patients.
Kim PW; Harris AD; Roghmann MC; Morris JG; Strinivasan A; Perencevich EN
Antimicrob Agents Chemother; 2003 Sep; 47(9):2882-7. PubMed ID: 12936989
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics, antimicrobial susceptibilities, and outcomes of patients with Chryseobacterium indologenes bacteremia in an intensive care unit.
Chou DW; Wu SL; Lee CT; Tai FT; Yu WL
Jpn J Infect Dis; 2011; 64(6):520-4. PubMed ID: 22116334
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
Etienne M; Van Elslande H; Choplin-Renard J; Pestel-Caron M; Caron F
Med Mal Infect; 2014 May; 44(5):217-22. PubMed ID: 24787633
[TBL] [Abstract][Full Text] [Related]
18. Sepsis in a renal transplant recipient due to Citrobacter braakii.
Gupta R; Rauf SJ; Singh S; Smith J; Agraharkar ML
South Med J; 2003 Aug; 96(8):796-8. PubMed ID: 14515921
[TBL] [Abstract][Full Text] [Related]
19. Impact of previous use of antibiotics on development of resistance to extended-spectrum cephalosporins in patients with enterobacter bacteremia.
Lee SO; Kim YS; Kim BN; Kim MN; Woo JH; Ryu J
Eur J Clin Microbiol Infect Dis; 2002 Aug; 21(8):577-81. PubMed ID: 12226687
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of Raoultella ornithinolytica bacteremia.
Chun S; Yun JW; Huh HJ; Lee NY
Infection; 2015 Feb; 43(1):59-64. PubMed ID: 25367410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
